Published in Am J Pharm Educ on February 10, 2010
Lost productive time and cost due to common pain conditions in the US workforce. JAMA (2003) 6.60
Migraine prevalence, disease burden, and the need for preventive therapy. Neurology (2007) 6.57
Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2000) 4.86
Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ (2008) 4.41
Treatment of primary headache in the emergency department. Headache (2003) 2.95
Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med (2002) 2.82
Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med (2002) 2.77
Migraine in the United States: epidemiology and patterns of health care use. Neurology (2002) 2.49
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology (2004) 2.18
Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology (2003) 2.14
A positron emission tomographic study in spontaneous migraine. Arch Neurol (2005) 2.12
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache (2007) 2.09
Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache (2008) 1.95
Excessive acute migraine medication use and migraine progression. Neurology (2008) 1.83
Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache (2001) 1.80
Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology (2004) 1.66
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache (2009) 1.59
EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol (2006) 1.43
Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache (2007) 1.40
Direct cost burden among insured US employees with migraine. Headache (2007) 1.15
Classification of primary headaches. Neurology (2004) 1.08
The acute treatment of episodic and chronic migraine in the USA. Cephalalgia (2009) 1.03
Analysis of headache management in a busy emergency room in the United States. Headache (2008) 0.93
Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey. Headache (2005) 0.84
The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med (2008) 0.84
Morbidity and medication preferences of individuals with headache presenting to a community pharmacy. Headache (2004) 0.82
Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy (2003) 0.81
Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns. Headache (2005) 0.79
Should butalbital-containing analgesics be banned? Yes. Curr Pain Headache Rep (2002) 0.78
Responsiveness of migraine-ACT and MIDAS questionnaires for assessing migraine therapy. Headache (2008) 0.78
Headache education in colleges of pharmacy. Ann Pharmacother (2002) 0.78
Treatment-refractory migraine: the case for opioid therapy. Headache (2008) 0.77
Do butalbital-containing products have a role in the management of migraine? Pharmacotherapy (2002) 0.77
Development and construct validation of the pharmacists' care of migraineurs scale. Headache (2009) 0.77
Migraine in the emergency department: not a win-win situation. Headache (2003) 0.77
Reliability and validity of the migraine therapy assessment questionnaire. Headache (2002) 0.76
Pharmacist participation in the workforce: 1990, 2000, and 2004. J Am Pharm Assoc (2003) (2006) 2.23
Pharmacists' attitudes toward worklife: results from a national survey of pharmacists. J Am Pharm Assoc (2003) (2004) 1.94
Pharmacists' personal use, professional practice behaviors, and perceptions regarding herbal and other natural products. J Am Pharm Assoc (2003) (2003) 1.85
Practice characteristics of bachelor of science and doctor of pharmacy degreed pharmacists based on the 2009 National Workforce Survey. Am J Pharm Educ (2010) 1.66
Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Res Social Adm Pharm (2007) 1.53
Finding a path through times of change. Am J Pharm Educ (2013) 1.48
Organizational factors influencing pharmacy practice change. Res Social Adm Pharm (2011) 1.48
Should I stay or should I go? The influence of individual and organizational factors on pharmacists' future work plans. J Am Pharm Assoc (2003) (2007) 1.47
Patients' expectations and their satisfaction with pharmacy services. J Am Pharm Assoc (Wash) (2002) 1.43
Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003) (2006) 1.42
Exploring prescription drug coverage and drug use for older americans. Ann Pharmacother (2002) 1.42
Promotion of prescription drugs to consumers: case study results. J Manag Care Pharm (2003) 1.38
Television advertisement format and the provision of risk information about prescription drug products. Res Social Adm Pharm (2005) 1.35
A modified model of pharmacists' job stress: the role of organizational, extra-role, and individual factors on work-related outcomes. Res Social Adm Pharm (2008) 1.31
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications (2009) 1.16
Addressing the issue of channeling bias in observational studies with propensity scores analysis. Res Social Adm Pharm (2006) 1.14
Third-year pharmacy students' work experience and attitudes and perceptions of the pharmacy profession. Am J Pharm Educ (2008) 1.11
Osteoporosis beliefs and antiresorptive medication use. Maturitas (2005) 1.02
Construct identification and measure development for investigating pharmacist-patient relationships. Patient Educ Couns (2003) 1.00
Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising. Clin Ther (2005) 0.95
Community pharmacists' work environments: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003) (2006) 0.94
Student pharmacists and medication reconciliation upon hospital admission: proposing a way to meet ASHP 2015 objective 1.1. J Am Pharm Assoc (2003) (2008) 0.94
Factors influencing pursuit of residency training. Am J Health Syst Pharm (2005) 0.90
Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy (2010) 0.86
Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications. Clin Ther (2008) 0.86
Examining gender salary disparities: an analysis of the 2003 multistate salary survey. Res Social Adm Pharm (2006) 0.86
Pharmaceutical expenditures as a correlate of population health in industrialized nations. Ann Pharmacother (2008) 0.85
Impact of pharmacists' directive guidance behaviors on patient satisfaction. J Am Pharm Assoc (Wash) (2002) 0.84
Health utilities in patients with HIV/AIDS in Thailand. Value Health (2010) 0.83
Psychometric properties of WHOQOL-BREF-THAI in patients with HIV/AIDS. J Med Assoc Thai (2007) 0.83
Citizen's preferences regarding principles to guide health-care allocation decisions in Thailand. Value Health (2008) 0.82
Morbidity and medication preferences of individuals with headache presenting to a community pharmacy. Headache (2004) 0.82
Automated medication-dispensing system in two hospital emergency departments. Am J Health Syst Pharm (2005) 0.82
PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Res Social Adm Pharm (2010) 0.81
Career pathways for pharmacists. J Am Pharm Assoc (2003) (2003) 0.81
Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm (2007) 0.80
Topiramate for migraine prevention. Pharmacotherapy (2006) 0.77
Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted? Ann Pharmacother (2008) 0.77
Pharmacist-administered admission histories: focus on immunizations in medication reconciliation. Ann Pharmacother (2008) 0.77
The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Res Social Adm Pharm (2005) 0.76
Trends in pharmacist participation in the workforce, 2009 to 2014. J Am Pharm Assoc (2003) (2016) 0.75
Building capacity for pharmacist-provided patient care services. J Am Pharm Assoc (2003) (2011) 0.75
Establishing pathways for access to pharmacist-provided patient care. J Am Pharm Assoc (2003) (2015) 0.75
Exploring trends and determinants of pharmacist wage rates: evidence from the 2000 and 2004 National Pharmacist Workforce Survey. J Am Pharm Assoc (2003) (2008) 0.75
Quantifying the opportunity for pharmacists to improve management of hypertension in a primary care medical clinic. J Manag Care Pharm (2008) 0.75
Exploring pharmacists' perceived job alternatives: Results from the 2014 National Pharmacist Workforce Survey. J Am Pharm Assoc (2003) (2016) 0.75
Consumers' characteristics associated with the use of mail pharmacy services in the United States: Findings from the 2015 National Consumer Survey on the Medication Experience. J Am Pharm Assoc (2003) (2016) 0.75
Patient characteristics predicting the frequency of medication therapy management visits for patients with diabetes. Clin Ther (2013) 0.75
Pharmacists' perspectives on postgraduate training. Am J Health Syst Pharm (2011) 0.75
The social network paradigm and applications in pharmacy. Res Social Adm Pharm (2012) 0.75
Influences on the frequency and type of community pharmacy services. J Am Pharm Assoc (2003) (2016) 0.75
Effects of anthropomorphic images and narration styles in promotional messages for generic prescription drugs. Res Social Adm Pharm (2012) 0.75
Older adults' drug benefit beliefs: a focus group study. J Manag Care Pharm (2005) 0.75
Physician perceptions of pharmacist provision of outpatient medication therapy management services. J Am Pharm Assoc (2003) (2006) 0.75
Assessing the efficiency of hospital pharmacy services in Thai public district hospitals. Southeast Asian J Trop Med Public Health (2008) 0.75
Improving medication therapy management through collaborative hospice care in rural Minnesota. J Am Pharm Assoc (2003) (2010) 0.75
Medication discrepancies associated with subsequent pharmacist-performed medication reconciliations in an ambulatory clinic. J Am Pharm Assoc (2003) (2015) 0.75
The certainty in consumers' willingness to accept pharmacist-provided medication therapy management services. J Am Pharm Assoc (2003) (2017) 0.75